- Home
- GF vs HRTX Comparison
GF vs HRTX Comparison
Compare GF & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GF
- HRTX
- Stock Information
- Founded
- GF 1990
- HRTX 1983
- Country
- GF Germany
- HRTX United States
- Employees
- GF N/A
- HRTX N/A
- Industry
- GF Investment Managers
- HRTX Biotechnology: Pharmaceutical Preparations
- Sector
- GF Finance
- HRTX Health Care
- Exchange
- GF Nasdaq
- HRTX Nasdaq
- Market Cap
- GF 183.3M
- HRTX 214.5M
- IPO Year
- GF N/A
- HRTX 1987
- Fundamental
- Price
- GF $10.55
- HRTX $1.11
- Analyst Decision
- GF
- HRTX Strong Buy
- Analyst Count
- GF 0
- HRTX 2
- Target Price
- GF N/A
- HRTX $4.50
- AVG Volume (30 Days)
- GF 28.1K
- HRTX 1.9M
- Earning Date
- GF 01-01-0001
- HRTX 11-04-2025
- Dividend Yield
- GF 0.82%
- HRTX N/A
- EPS Growth
- GF N/A
- HRTX N/A
- EPS
- GF N/A
- HRTX N/A
- Revenue
- GF N/A
- HRTX $155,097,000.00
- Revenue This Year
- GF N/A
- HRTX $10.62
- Revenue Next Year
- GF N/A
- HRTX $12.99
- P/E Ratio
- GF N/A
- HRTX N/A
- Revenue Growth
- GF N/A
- HRTX 12.60
- 52 Week Low
- GF $7.38
- HRTX $1.04
- 52 Week High
- GF $9.41
- HRTX $2.68
- Technical
- Relative Strength Index (RSI)
- GF 33.53
- HRTX 34.91
- Support Level
- GF $10.10
- HRTX $1.05
- Resistance Level
- GF $11.33
- HRTX $1.28
- Average True Range (ATR)
- GF 0.22
- HRTX 0.08
- MACD
- GF -0.06
- HRTX -0.01
- Stochastic Oscillator
- GF 39.79
- HRTX 21.15
About GF New Germany Fund Inc. (The)
NEW GERMANY FUND INC is a non-diversified, closed-end management investment company. As the investment objective, the fund seeks long-term capital appreciation through investment in middle-market German equities. The fund's portfolio of investment includes investments in different sectors such as the industrials, information technology, material, consumer discretionary, Communication Services, Financials, Consumer Staples, Real Estate, Utilities, Healthcare, Energy, and others. Its portfolio is geographically diversified across the Netherlands, Germany, and Luxembourg.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.